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Abstract
Background: Studies suggest that lutein and zeaxanthin may be important for
cognitive development in children, but a comprehensive evidence synthesis is
lacking. The purpose of this evidence synthesis was to analyse the available
data regarding the role of lutein and zeaxanthin for cognition in children and
propose a theoretical basis for future studies.
Methods: The PubMed, Scopus, the ISRCTN registry and Cochrane Library
databases were searched for studies that evaluated the relationship between
lutein and zeaxanthin and cognitive function in children. Reference list and
ancestry searches were performed on relevant articles. A total of 543 articles
were identified, of which six cross-sectional studies were included.
Results: The literature search revealed that the evidence concerning the effect
of lutein and zeaxanthin on cognition in children is sparse. However, there is
some preliminary evidence indicating a positive association between lutein and
zeaxanthin and cognition in childhood.
Conclusions: The cross-sectional nature of the few studies available and the
lack of RCT data indicates a need for further investigation before any firm
conclusions can be drawn.
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Introduction

Methods

The dietary carotenoids lutein and zeaxanthin preferentially
accumulate in neural tissue including the central region of the
retina (macula) where they form macular pigment (MP). MP’s
constituent carotenoids have been studied extensively for
their role in eye health and in the prevention of retinal disease
such as age-related macular degeneration (AMD) and, more
recently, glaucoma1,2. Within the eye, the protective role of MP
appears to relate to its light-filtering, antioxidant, anti-inflammatory and neuro-protective properties3,4. These carotenoids
are also found in several specific regions in the brain including
the frontal, occipital and temporal cortices, hippocampus and
cerebellum from prenatal development into old age5–8. Retinal
MP can be measured non-invasively and used as a surrogate
measure of brain lutein and zeaxanthin status5. The selective
accumulation of these carotenoids in the brain suggests that they
may have a specific role within the central nervous system.

There is insufficient available evidence to support a full systematic review. An evidence synthesis was, therefore, conducted
by performing a comprehensive literature search using the
following major databases: PubMed, Scopus, the ISRCTN registry and Cochrane Library with the following search items:
“lutein” or “zeaxanthin” or “macular pigment” or “carotenoids”
AND “cognitive function” or “memory” or “attention” or “reaction
time” or “brain” AND “children” or “childhood” or “infants” or
“infancy” or “premature” or “prematurity” or “adolescent”.

So far the beneficial effects of lutein and zeaxanthin have
been primarily studied in relation to older age, due to the
antioxidant, anti-inflammatory and neuroprotective properties
of these carotenoids and the fact that oxidative stress and inflammation have been implicated as pivotal components of agerelated visual and cognitive decline9–11. Indeed, higher levels of
MP in the diet, serum, eye and in the brain later in life have been
shown to be associated with better cognition12–17. At the same
time, these compounds are present in the eye and brain from an
early age, suggesting that they have an important biological role
throughout life8,18,19. The possible importance of these carotenoids for cognitive development is indicated by the selective
accumulation of lutein and zeaxanthin within the developing
infant brain8. Lutein, in particular, is the predominant carotenoid in the brain tissue from infancy8. Despite constituting just
12% of overall infant carotenoid intake, lutein has been shown
to account for 59% of total brain carotenoids8. Additionally,
the relative contribution of lutein to total carotenoids is almost
two-fold greater in the infant brain than in adults, accounting
for 59% vs. 34%, respectively8,20. Lutein and zeaxanthin’s concentrations in the eye are still 2-3 times higher than in the brain5.
Nevertheless, such selective concentration of lutein, and the
multitude of effects it has on neural cell viability, suggests that
it may play a key role in the early processes of neural and
hence cognitive development in children8,20–23.
The aims of this paper are three-fold. Firstly, given that childhood
is a critical period for brain development, this evidence synthesis aims to analyse the available evidence regarding the possible
role of lutein and zeaxanthin for neural development and cognitive function in children. Additionally, the available evidence is
explored to identify plausible mechanistic processes through
which lutein and zeaxanthin might influence cognitive
development. Lastly, given that the circulating levels of lutein
and zeaxanthin available for uptake into neural tissue are dependent on their consumption in the diet, the evidence in relation to
dietary intake of these phytonutrients in children is also appraised.
Such an analysis may be useful as a means to inform dietary
recommendations for the optimisation of cognitive development in
children.

Inclusion and exclusion criteria
Types of studies
The evidence synthesis was confined to peer-reviewed publications. Clinical studies were included as a means to elucidate the
evidence that lutein or zeaxanthin status might be associated
with or impact cognition in children. Multiple study designs
were considered eligible including: meta-analyses, randomised
and non-randomised clinical trials, cohort studies and crosssectional studies involving children (<18 years of age). Non-peer
reviewed publications, animal studies, case studies, abstracts,
reviews, studies where the full text was not retrievable and
studies where the outcomes were deemed not directly related to
cognition (e.g. head circumference, broad biomarkers such as
activin A) were all considered ineligible for inclusion.

Phenomenon of interest
The phenomenon of interest in this analysis was the relationship between dietary intake (including breast milk), serum and/or
macular concentrations of lutein and zeaxanthin, and cognition in
children.
The final search was conducted in May 2018. No language or
date restrictions were used in the electronic searches for trials.
This search resulted in a total of 543 potential eligible articles.
Two investigators independently reviewed the titles, abstracts
and full text of the resulting articles for inclusion. The reference list of each publication meeting the inclusion criteria was
examined and ancestry searches were performed on relevant
review articles to identify any further studies that were not found
using the electronic search. The overall search resulted in the
inclusion of six cross-sectional studies, five of which are specific
to the effects of lutein or zeaxanthin, while one study reported
findings for lutein in combination with the non-carotenoid compound, choline. Data extraction was conducted manually, using
the following categories: author, year, methodology, results,
conclusions. Qualitative evidence synthesis was then conducted,
including assessment of methodological limitations of articles
selected for inclusion. Given the qualitative nature of this analysis, no statistical methods were used. Figure 1 below summarises
the studies retrieved.
In order to provide mechanistic explanations for any relationships observed between lutein and/or zeaxanthin and cognition in children, additional sources of evidence were explored
in the part II of the evidence synthesis including systematic and
non-systematic reviews, in-vitro studies, and studies involving
adult participants.
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Figure 1. Search strategy and results for clinical studies exploring the relationship between lutein and zeaxanthin and cognition in
children.

Results
Evidence concerning the effect of lutein and zeaxanthin on
cognition in children
The evidence concerning the effect of lutein and zeaxanthin on
cognition in children is relatively sparse. Interestingly,
however, the evidence that does exist spans the entire range of
early childhood development, including from gestation up to the
beginning of adolescence (see Table 1).
Although not directly indicative of cognitive function, an
investigation of the relationship between arterial cord blood
lutein concentrations and activin A, a glycoprotein implicated
in the response to acute neuronal damage (e.g. brain injury),
provides the earliest indication as to the importance of lutein24.
Lutein was shown to correlate positively and significantly
with activin A in both male and female populations (p < 0.001
for both). Moreover, both lutein and activin A concentrations
showed gestational age-dependent patterns, with peaked concentrations at 33–36 weeks and decreasing from 37 weeks
onwards reaching a dip at term. Of note, 33–36 weeks of
gestational age is a period of very active central nervous system
(CNS) development25,26. The peak of arterial blood lutein concentrations during this period, therefore, suggest the possibility of a specific role for this carotenoid in supporting maturation
of the CNS.
Progressing into infancy, a study of 55 six-month-old infants
explored the association between human breast milk nutrients
(lutein, choline and docosahexaenoic acid (DHA)) and infant

recognition memory27. The study revealed that the synergism
of higher breast milk lutein with choline was related to better
infant recognition memory, which was tested using an eventrelated potential oddball paradigm. The combined effect was also
observed between high choline and DHA. This study was unique
in that it evaluated a measure of cognition so early in life. A
cautionary interpretation of the findings is necessary, however,
as lutein was not analysed as a single ingredient, and because
there was a lack of concurrent cognition and milk nutrient
measures, whereby human milk was obtained and analysed
at three to four months post-partum and infant cognition
was evaluated following a further two to three months of
development.
Among older children, one study in five-year-olds failed to
find a significant association between serum concentrations of
lutein and cognitive function28. This study utilised the Kaufman
Assessment Battery, an indicator of children’s intelligence
quotient (IQ), finding no relationship between the overall score
or the subscale scores and lutein. However, the chosen parameters for lutein status were serum lutein and self-reported lutein
intake, neither of which are reliable indicators of brain lutein
levels29. Furthermore, this study used a population that was
particularly well-nourished with an estimated average lutein
intake nearly four times higher than that observed in a sample of
four to eight year olds in the US National Health and Nutrition
Examination Survey (NHANES) survey23. As the population
in this study was thereby at low risk for nutrient deficiency, this
could have contributed to the lack of detected association.
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Table 1. Studies exploring the relationship between MPOD, lutein and zeaxanthin (L & Z) dietary intake, plasma and mother’s breast
milk lutein with cognition in children.
Author (year) Number of
participants

Age

L & Z status
assessment

Measures of Cognitive
Performance

Results

Cheatham
et al. (2015)

55

6 months Breast milk lutein,
choline and
docosahexaenoic acid

70-30 oddball paradigm
Higher choline levels in combination with
in a high-density 128-lead higher lutein levels were related to better
event-related potential
recognition memory (p < 0.05).
(ERP) paradigm

Mulder et al.
(2014)

160

5.6–5.9
years

Plasma lutein
Dietary intake
(FFQ, 24h recalls)

Kaufman Assessment
Battery II (KABC-II)
Peabody Picture
Vocabulary Test-4 (PPVT)

No significant associations between
serum lutein and PPVT and KABC-II

Barnett et al. 56
(2017)

8–10
years

MPOD (cHFP)
Dietary intake
(FFQ, 24h recalls)

Kaufman Test of Academic
and Educational
Achievement II
IQ

MPOD was positively related to
academic achievement (p < 0.01),
mathematics (p = 0.02), and written
language composite standard scores
(p < 0.01), even after accounting for
IQ, sex, aerobic fitness and body
composition.

Saint et al.
(2018)

51

7–13
years

MPOD (cHFP)

Woodcock-Johnson III
tests of cognitive abilities

MPOD was significantly related to
executive processes (p < 0.05), and
brief intellectual ability (p < 0.05).

Walk et al.
(2017)

49

8–10
years

MPOD (cHFP)

Flanker test
Higher MPOD was related to significantly
EEG during computerised higher accuracy on the flanker task for
flanker test
incongruent trials (p = 0. 17). MPOD was
inversely related to P3 EEG amplitudes,
significant for incongruent trials
(p = 0.039).

Hassevoort
et al. (2017)

40

7–10
years

MPOD (cHFP)

Relational memory

MPOD and aerobic fitness associated
negatively with relational memory errors
(p < 0.01), central adiposity associated
positively with relational memory errors
(p < 0.05).

Abbreviations: MPOD, Macular pigment optical density; FFQ, food frequency questionnaire; IQ, intelligence quotient; cHFP, customized heterochromatic flicker
photometry; EEG – electroencephalograph

Academic performance, a global indicator of cognitive function, was also assessed in slightly older children, aged eight
to nine years30. Retinal MP levels, which are considered to be
reliably associated with lutein concentration in the brain5, were
measured using customised heterochromatic flicker photometry (cHFP), a technique shown to provide reliable measures of
MP optical density (MPOD) in preadolescent children31. This
study demonstrated that MPOD was positively related to
academic achievement, mathematics and written language
composite standard scores, even after accounting for IQ, sex,
aerobic fitness and body composition. Correlations between
dietary intake of lutein and zeaxanthin and the same academic
parameters were not consistent, which is not surprising given
the limitations of serum lutein and zeaxanthin as an indicator of
tissue concentrations.
The above findings are supported by the most recent crosssectional study which explored the association between MPOD
and standardised measures of cognitive functioning in 51 preadolescent children aged seven to thirteen years32. Cognition was
measured with the Woodcock-Johnson III battery, particularly
those tests related to the subcomponents of brief intellectual
ability (verbal comprehension, concept formation, and visual

matching), verbal ability, cognitive efficiency, processing speed,
and executive processes. MPOD was a statistically significant
predictor of performance for the brief intellectual ability and for
executive processes. Exploratory analysis showed that performance on the spatial relations subtest (a measure of visual-spatial
thinking, not included in the calculation of cluster scores) was
also statistically significantly related to MPOD. The relationship between MPOD and cognitive efficiency was not significant
(r = 0.206, p = 0.074).
In a study by Walk et al. children were asked to perform a
modified version of the flanker task, which measures the capacity to selectively attend to a target, while ignoring distractors33.
In this study, MPOD was associated with more accurate task
performance and lower P3 amplitude of the electroencephalogram (EEG)33. The relationships were more pronounced for trials
with high cognitive load. The authors interpret their findings to
suggest that children with higher MPOD complete the task
more efficiently relative to those with lower MPOD. Therefore,
reduced P3 amplitude in participants with higher MPOD could
indicate that those kids needed fewer attentional resources to
complete the same task compared to the subjects with lower
MPOD. The MPOD-dependent variation observed in the
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behavioural and electrophysiological (EEG) indices elicited
during the cognitive control (flanker) task would lend support to
such an interpretation.
It appears that MPOD is also positively associated with relational memory in preadolescent children, even when controlling
for aerobic fitness and central adiposity34. Interestingly, aerobic
fitness was also related to relational memory, but MPOD and
aerobic fitness were not associated with each other, suggesting
that they may contribute to cognitive performance by different
mechanisms. On the other hand, central adiposity was significantly associated with relational memory errors, consistent with
previous studies in children and in adults35,36.

Proposed mechanism of lutein and zeaxanthin action on
cognitive development
In order to describe the possible mechanisms of action through
which lutein and zeaxanthin might exert a developmental
influence on cognition in children, it is necessary to explore
their localisation in the brain, their possible role in early growth
and maturation of the brain and the neuro-enhancing influences
they may exert as a child develops. In this evidence synthesis,
we will also explore a more indirect pathway through which the
presence of these carotenoids in high concentrations in the eye
might also exert a cognitive influence.

Lutein and zeaxanthin in the eye and brain
Anatomically and developmentally, the retina is a part of the
central nervous system, and both retina and optic nerve originate
as outgrowths of the developing brain. The retina and the brain
share a number of similarities, including anatomy, functionality,
immunology and response to insult37. The retina contains a layer
of specialised neurons, the retinal ganglion cells (RGCs), which
exhibit properties typical of CNS neurons.

Relative concentrations
It is well established that lutein and zeaxanthin are present in the
eye and in the brain. These two carotenoids have been found in
ocular tissues from 18 weeks of pre-natal development, while in
the brain they have also been found in preterm infants8,18. The
study in preterm infants showed that lutein was a predominant
carotenoid in all 5 brain regions analysed (mean concentrations ranging from 40.7 ± 7 pmol/g in hippocampus to 55.52
± 18.33 pmol/g in the auditory cortex). The concentrations
of zeaxanthin ranged from 10.03 ± 2.46 pmol/g in prefrontal
cortex to 17.8 ± 3.94 pmol/g in the auditory cortex, considerably
lower than lutein.
Lutein was shown to be the predominant carotenoid in the brain
of older adults too, although in older adults is accounted for
30% of total carotenoids, compared to 59% of total carotenoids
in the infant brain5,8. In older adults, the ratio of brain to ocular
lutein (~ 0.4) was slightly higher than brain to retinal zeaxanthin
(~ 0.27), but broadly comparable. The ratio in infants has not
yet been studied. However, the studies directly relevant to this
review focused on either MPOD or breast milk or serum lutein
(and not zeaxanthin), so the subsequent analysis will focus on
lutein as there is not currently enough evidence to define the
possible role of zeaxanthin specifically.

Carotenoid role in brain tissue
In the infant brain, lutein and zeaxanthin have been identified
in prefrontal, frontal, auditory and occipital cortices, and
hippocampus8,19. As described earlier, the infant brain appears to
be exquisitely sensitive to lutein, capable of accumulating circulating dietary lutein so effectively that it comprises the dominant
carotenoid in brain tissue despite limited intake8. That lutein
concentration is so much higher in infant relative to adult brain
suggests that the effects of lutein are increasingly important in
early life. The presence of lutein and zeaxanthin in visual and
auditory areas of the brain, as well as in areas associated with
executive function and memory, is consistent with associations
reported in older children, including possible influences on
visual recognition memory in infants27, relational memory34,
executive processes and academic performance30,32.
Mechanisms by which lutein and zeaxanthin are believed to
protect the retina, such as their antioxidant, anti-inflammatory
and neuroprotective action, are likely to apply to the brain as
well38. Such neuroprotection is particularly important during
infancy when the CNS is developing at a very fast pace. The
membranes of the brain and retinal cells contain high quantities of the long-chain omega-3 PUFAs, including docosahexaenoic acid (DHA) - the main n-3 PUFA in the brain, which is
essential for maturation of the CNS, but also is easily susceptible to oxidation39. DHA is known to regulate immune function
and microglia activation with its derivatives exerting antiinflammatory and proresolving effects39. Alterations of PUFA
metabolism in the brain can be detrimental and lead to neuroinflammatory events. Lutein, as a potent lipophilic antioxidant
that is differentially localised in the membrane domains rich in
PUFAs, is well positioned to protect these important lipids40.
A strong relationship has been shown to exist between brain
lutein concentration and StARD3, an integral membrane
protein which is proposed to be involved in intracellular lipid
trafficking. Interestingly, the relationship is strongest during
infancy (r = 0.75, P < 0.001), is weaker among older adults
(r = 0.51, P < 0.05) and becomes insignificant in centenarians
(r = 0.08, P > 0.05), perhaps again suggesting a specific role
for lutein in early neural development19. Lutein’s potential role in
brain growth and maturation is further supported by findings
that it’s content in brain tissue correlates with levels of brain
amino acid neurotransmitters (gamma-aminobutyrate, aspartate),
neurobiomarkers (activin A) and metabolites of energy pathways
(1-octadecanol, phosphate and NADH)41.

Antioxidant and anti-inflammatory mechanisms of action of
carotenoids in brain
Although there is no direct evidence in relation to the infant
brain, animal studies have recently provided evidence for a direct
effect of carotenoids on the brain through anti-inflammatory
and antioxidative mechanisms. Treatment of rats with lutein
protected against traumatic brain injury as assessed by a forelimb reach test, and attenuated the increased levels of reactive
oxygen species, COX-2, and pro-inflammatory factor NF-kB
in the hippocampi of these animals. Concurrently, upregulated
levels of Nrf-2, a transcription factor that regulates the expression of antioxidant proteins that protect against oxidative
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damage triggered by injury and inflammation was observed in
the hippocampus42. Another recent report using an animal
model, demonstrated that lutein attenuates inflammatory hyperalgesia associated with trigeminal nociceptive neurons in rats
through inhibition of COX-243. The direct anti-inflammatory and
antioxidant effects of lutein in brain cells has also been
explored through its action on microglia. Microglia are the
resident immune cells of the brain and when activated develop
into either one of two phenotypes, a classically activated
pro-inflammatory (M1) phenotype which release inflammatory
molecules including cytokines, nitric oxide and other reactive
oxygen species that have been shown to have a negative effect
on neuronal and cognitive function, or an alternatively activated
(M2) phenotype which are primarily involved in neuroprotection by releasing anti-inflammatory cytokines and neurotrophic
factors44. M1 primed microglia treated with lutein in vitro
resulted in a suppression of the release of the oxidative species inducible nitric oxide synthase (iNOS), cyclooxygenase-2
(COX-2), nitric oxide (NO) and pro-inflammatory cytokines
tumour necrosis factor-α (TNF-α) and interleukin-1β (IL-1β)
demonstrating a direct antioxidant and anti-inflammatory effect
of lutein in brain cells45. Interestingly, when the effect of combinations of DHA, eicosapentaenoic acid (EPA) and lutein
were assessed for their capacity to prevent the release of
oxidative and pro-inflammatory mediators from M1 microglia
in vitro, results show a synergistic inhibition of NO, prostaglandin E2 (PGE2), iNOS, COX-2, IL-6, and an increase in the
release of anti-inflammatory IL-10 from microglia46. These
data provide a potential brain-specific cellular mechanistic
explanation of recent preliminary clinical evidence demonstrating that a combination of lutein and zeaxanthin with the
omega-3 PUFAs, DHA and EPA enhanced memory and mood
in a cohort of Alzheimer’s patients47. Thus, as PUFAs are neuroprotective yet vulnerable to oxidation, strategies for dietary
interventions that combine PUFAs with the antioxidative
properties of carotenoids are worthy of investigation not just
for age-related cognitive decline, but for cognitive development in
children.

Neuro-enhancement
Lutein and zeaxanthin’s protective action on cell viability and
their role in ocular and neurological disease such as retinopathy of prematurity (ROP), AMD and Alzheimer’s disease is
well documented48–51. Their ability to improve and optimise
function of healthy neural tissue, however, suggests that lutein
and zeaxanthin may have additional neuro-enhancing effects.
Optimal cognitive performance in different age groups and in
the absence of disease has been shown to be associated with
plasma, retinal and brain concentrations of lutein and zeaxanthin, and to be enhanced by supplementation with these
carotenoids12,52–55. The neuro-protection offered by lutein and
zeaxanthin is unlikely to account for the observed relationship between these compounds and dynamic brain function in
relatively young healthy subjects56,57. Although the exact mechanism behind this observed neuro-enhancement is not clear, there
are a few plausible routes whereby lutein and zeaxanthin may
improve neural function.

Stabilisation of membranes, modulation of their activity58 and
enhancement of intracellular communication are among the
suggested mechanisms of action of these carotenoids22,59. Lutein
concentration in the infant brain has been demonstrated to
correlate with fatty acids and lysophospholipid levels in the
frontal cortex and hippocampus, which are known to mediate
neuronal signal conduction41. It has also been demonstrated that
supplementation with lutein in diabetic mice prevents degradation of the synaptic vesicle protein synaptophysin, a marker of
synaptic density60. It is possible that lutein and zeaxanthin
increase processing speed through their facilitative effect on
gap junctional communication61. Gap junctions are cell-to-cell
channels formed by connexin proteins that allow signalling
compounds to pass freely between cells62. These channels are
believed to be important for the maturation of neural circuitry as
they play a role in light processing within the retina63,64.
Unlike nonpolar carotenoids such as β-carotene and lycopene,
lutein has polar groups at each end of the molecule which are
believed to allow the molecule to span the membrane in a perpendicular or semi-perpendicular orientation to the membrane
surface65,66. Together with their high solubility in membranes,
this characteristic can positively influence membrane properties
including fluidity, ion exchange, oxygen diffusion and membrane stability67, as well as conferring a protective influence in
making membranes less sensitive to oxidative damage68.
Lutein and zeaxanthin may also play a role in maintaining cell
integrity and plasticity, by binding to tubulin, the major
structural protein of microtubules69,70. Being integral to the
cytoskeleton, microtubules are important for mechanical, transport, communicative and signalling purposes71. These carotenoids may modulate the dynamic instability of microtubules (the
combination of assembling, disassembling, and rapid transitions
between the two), and thereby promote cell integrity70.
Although the primary influences of lutein and zeaxanthin on
early cognitive development are likely mediated through their
selective accumulation directly in brain tissue as outlined above,
it is perhaps also worth speculating herein as to the possible
benefits that their co-location in the eye might deliver beyond
vision and into cognition. The role of MP in the eye is well
established. The visual benefits of MP relate to its antioxidant,
anti-inflammatory and optical properties, while there is a
growing body of evidence that lutein and zeaxanthin may also
have a favourable effect on neuronal processing56,72. They may
also, however, play an important role in visual development.

Ocular influences
In early life, the retina is particularly vulnerable to oxidative
stress and inflammation due to immature autoregulation of blood
flow in the choroid, increased metabolic activity and increased
exposure to short wavelength light due to a highly transparent
crystalline lens73. The rationale for the proposed role of lutein
and zeaxanthin in visual system development is based on findings that these carotenoids are present in ocular tissue from 18
weeks of pre-natal development18. Additionally, supplementation

Page 7 of 16

HRB Open Research 2019, 2:8 Last updated: 14 MAY 2019

studies of lutein in infants, particularly those with ROP, have
shown possible benefits. Supplementation with lutein in
the first hours of life can reduce neonatal oxidative stress74,
which is particularly important for new-borns whose antioxidant
system has not yet developed. Oxidative stress and resulting
inflammation are inextricably linked to the pathogenesis of
common diseases of prematurity, such as ROP75. Additional
benefits have been shown with lutein supplementation in
infants, including reduced inflammation76, and even decreased
ROP severity50. An RCT in preterm, very low-birth-weight
neonates showed that supplementation with lutein and zeaxanthin resulted in 50% decreased progression rate from early ROP
stages to threshold ROP50. MP’s antioxidant, anti-inflammatory and immuno-modulatory properties may, therefore, provide
protection to the vulnerable developing retina and potentially
brain77–80, and thereby influence visual and possibly cognitive
development81.
It is well established that preterm infants more often develop
neurological problems than term infants, with the level of
impairment ranging from subtle cognitive abnormalities to
severe neurological handicap82,83. Even low risk premature
infants have lower scores for cognitive development at 3-4 years
of age84. Preterm children without measurable neurological
damage perform worse on visual perception and visual motor
integration tasks, as well as memory, sustained attention and
picture vocabulary tests84. Interestingly, MP levels have been
shown to relate to such tasks in adults, including visual motor
response85 and visual-spatial functioning72. A number of factors
could contribute to the development of cognitive deficits in preterm infants, including the same mechanisms of oxidative
stress and inflammation involved in ROP pathogenesis. Preterm
infants also have brain lutein and zeaxanthin levels that are
lower than in the full-term infants8. Lutein and zeaxanthin may,
therefore, be uniquely suited to protect the premature brain,
as well as retina, from the sudden increase in oxygen levels
experienced after birth, compared to in utero.

Vision’s contribution to cognitive development
Although normal vision is not a prerequisite for normal
cognitive development, in sighted individuals, vision is one
of the main drivers of development through observation and
facilitating exploration of the environment. In sighted individuals, vision is generally the dominant sense86,87. Indeed, in
sighted individuals, vision-led functions such as distinguishing
shapes are important for development of shape bias and
associated language learning88. Motion perception is key to
categorisation of objects89, which in turn, is linked to semantic
memory. Additionally, imitation, which is a fundamental
aspect of learning, is grounded in action and movement
recognition90,91. In later life, vision appears to support the
maintenance of cognitive health, with loss of vision associated
with a decline in memory92.
There is some indirect evidence from various sources to support
the view that optimised vision (which may be influenced by
MP levels) may be a refining factor for optimal neurocognitive
development. Firstly, the cortical areas corresponding to the
fovea are greatly magnified, with about half of the primary

visual cortex devoted to processing information from the
macula, reflecting the importance of this area for later information processing by the more anterior portions of the brain93.
Moreover, the development of sensory networks, and particularly
visual ones, is prioritised over motor networks, suggesting the
special role of vision for overall development94.
According to the “effortfulness” hypothesis first proposed by
Rabbitt in 1968, an individual’s cognitive processes can be
affected by increased effort required when trying to identify
degraded sensory input95. It is possible, therefore, that degraded
(or non-optimised) visual input may put increased demand on
cognitive resources and thereby deprive other cognitive activities. It has also been demonstrated that even a modest reduction in image quality can have a marked effect on the speed
of response on cognitive tests in both younger and older
adults96,97. In the eye, MP acts as a pre-receptoral optical filter
that serves to optimise and refine the visual signal to be delivered
to the brain98. How much suboptimal vision and any associated
“effortfulness” could affect an individual’s cognitive development
long-term remains, however, unclear.
There is evidence that vision impairment can affect language
and communication development in children, especially during
the early stages99. Moreover, perceptual processes later in life
and normal development of the neural architecture appear to
depend to a significant degree upon the early visual input
received. The deprivation of patterned visual input due to
congenital cataracts in new-borns has been shown to result, for
example, in permanent deficits in configural face processing,
a function mediated by both vision and cortical mechanisms,
even after more than nine years’ recovery (cataracts were removed
at 2–6 months of age)100.
Whether the visual benefits of lutein and zeaxanthin outlined herein translate into cognitive benefits, however, remains
entirely speculative at this time. The benefit of sensory stimulation enhancement, if any, is likely to be small relative to its
broader effect inside the brain. There may be other, as yet
uncharacterised, roles and mechanisms of action through
which carotenoids can exert a positive influence in the developing retina and brain38. An overview of the various mechanisms by which lutein and zeaxanthin might influence cognitive
development are described in Figure 2.

Dietary intake of lutein and zeaxanthin from pre-natal
development into adult life
In humans, lutein and zeaxanthin cannot be produced endogenously and are, therefore, acquired entirely from dietary sources.
The deposition of these carotenoids in the body begins early
during pre-natal development, when they are obtained from
mother’s blood via placental transport101. Immediately after
birth, mother’s milk (or milk formula) becomes the sole source
of lutein and zeaxanthin with their respective concentrations in
human milk depending on a number of factors including the
stage of lactation, maternal intake of these carotenoids102,103, or
milk formula constituent ingredients. Once solid foods replace
mother’s milk, green leafy vegetables, fruit and eggs become
the primary sources of lutein and zeaxanthin, along with other
Page 8 of 16
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Figure 2. Schematic of the proposed mechanistic processes through which lutein and zeaxanthin might influence cognitive
development.

nutrients essential for normal development. If variations in brain
and/or ocular levels of lutein and zeaxanthin do indeed influence
cognitive development in children, it is important to consider
the evidence describing the intake of these carotenoids among
children.

Gestational Transfer
The transfer of lutein and zeaxanthin across the placenta is
believed to be dependent on their respective concentrations in
mother’s plasma, indicating a passive diffusion process and
emphasising the importance of mother’s diet during pregnancy
and lactation104. While lutein and zeaxanthin are detectable at
18 weeks gestation18,105, the concentrations of lutein and zeaxanthin within the eye increase with later gestational stages.
It appears that most lutein deposition occurs during the last
trimester8,106, which explains why lutein levels are much higher
in neural tissue among term infants when compared to pre-term
infants.

Lutein and zeaxanthin in human milk
Infancy is a critical period of rapid growth and maturation
which places high demands on nutritional intake. Human milk is
the sole source of nutrients for breast-fed new-born infants until

the introduction of solid food, and it provides for all the dietary
requirements during the first few months after birth, including
lutein and zeaxanthin103,107. In a nine-country survey conducted
on breast milk carotenoid composition among 471 women, the
overall mean ± SD for breast milk lutein plus zeaxanthin was
25 ± 19 µg/l, but individual country means varied three-fold,
from a low of 15 ± 5 µg/l in the U.S. to a high of 44 ± 18 µg/l in
Japan. The highest individual lutein concentration measured
was 232 µg/l in China and the lowest was 3 µg/l in the U.K, a
staggering 77-fold variation102. Interestingly, it appears that
breastfeeding and its duration may have effects on cognitive
development in children during their first three years of life108.
One study has shown that infants who were breastfed for ≥
9 months had significantly better cognitive development than
those who had not been breastfed, although this finding was not
explored in relation to nutrient concentrations in breast versus
formula milk109.
Although formula milk is designed to contain all the major
components of breast milk, breast milk remains the best source
of nutrients for infants and contains many additional factors110.
Lutein and zeaxanthin have been found in several formula
products, with lutein concentrations ranging from 0.7 to
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9.7 nmol/g fat and zeaxanthin ranging from 0.1 to 1.2 nmol/g
fat in those containing the carotenoids, while none was found in
other market-available formulations111.

months117. This low dietary intake pattern would seem to present
the risk of inadequate lutein and zeaxanthin consumption among
children.

Human milk samples analysed in this study had comparable
levels of lutein and zeaxanthin to the formula milk, with
median concentrations of 4.79 nmol/g fat (range 0.42-9.98) and
0.55 nmol/g fat (0.00-1.70) in human milk samples, respectively.
However, there is evidence to suggest that lutein in formula
milk has lower bioavailability than that in breast milk. One
study compared lutein levels in three groups of healthy term
formula-fed infants randomised to study formulas containing different concentrations of lutein (from 20 which was
considered unfortified to 225 µg /l of lutein) and a breastfed
reference group. It appears that the bioavailability difference
is such that approximately four times more lutein would be
needed for formula-fed infants to achieve similar serum
concentrations to breastfed infants112. It is plausible to suggest,
therefore, that the relative lack of lutein and zeaxanthin in
some formula milk, coupled with the reduced bioavailability of
formula derived sources could disadvantage formula-fed infants
with respect to carotenoid accumulation in macular and brain
tissue.

Some degree of variability has been observed in dietary intake
levels among older children. Analyses of a single 24 h diet
recall collected in the NHANES in 2003–2004 revealed that the
mean (SD) estimated lutein intake among 4–8 year old children
was just 311 µg/day (474), with intakes of 335 µg/day (730) for
children 9–13 years of age and 432 µg/day (1062) for those
14–18 years of age118. For comparison, in another more recent
study of 160 Canadian children (mean age 5.75 years), the
mean (SD) lutein intake based on 24 h recall records was
somewhat higher, at 1230 (2020) µg/day. This may suggest
higher intakes of lutein among children in that study, or possibly increased awareness and availability and hence intake of
lutein-rich foods over the decade since the 2003–2004 NHANES
survey28. However, the food sources accounting for the higher
intake of lutein were not identified. Another study of 13-17 year
old Canadian children using one 24-hour recall, reported a
mean (SD) lutein intake of 1132 (1888) (5th to 95th percentile
range 50-1306) µg/day for 84 males and 1331 (2090) (5th to 95th
percentile range 92-1561) µg/day for 94 females119. Of note,
the large standard deviation values indicate wide variation and
positive skewing in all these studies. The limitations of all
methods to quantify dietary intake of specific nutrients do need
to be acknowledged. Most importantly, however, dietary intake
analysis only provides intake estimates and does not account
for the absorption and distribution of carotenoids to target
tissues in the body.

Given individual and regional differences in breast milk
carotenoid concentration, dietary fortification among expectant
and lactating mothers merits consideration, and there is some
evidence to suggest this can be effective. Supplementing lactating mothers with a formula containing two different concentrations of lutein, in combination with docosahexaenoic acid
(DHA) and alpha-tocopherol for 6 weeks resulted in increased
total lutein and zeaxanthin in plasma and breast milk compared
to placebo113. The infants of mothers assigned to the low- and
high-dose lutein supplement also had a significantly greater
concentrations of total plasma lutein and zeaxanthin, which
correlated significantly with their mother’s breast milk total
lutein and zeaxanthin113.

Dietary intake
Green leafy vegetables are the major dietary source of lutein
and zeaxanthin once a child progresses to solid food. The two
carotenoids are found in many of the same foods and most dietary
databases include them together114.
The 2015-2020 Dietary Guidelines for Americans recommend
specific age-appropriate caloric and vegetable intake levels for
children. For children aged 1-3 (caloric intake 1000K), for
example, the recommended vegetable intake every week is
seven cups of vegetables. This includes 0.5 cup per week of dark
green vegetables- the richest sources of lutein and zeaxanthin in
the diet115. According to the 2002 Feeding Infants and Toddlers
Study (FITS), a national sample of US children 12–24 months
old, mean vegetable intake in this age group was just 2.8
cups per week with no documented intake of dark green
vegetables116. In another study, only 3.1% of non-Hispanic
children consumed dark green vegetables between the ages
of 6–11months increasing to 7.5% between the ages of 12–24

Recommended daily/dietary allowances (RDA) are recommendations for the minimum amount of a nutrient that is needed
for most individuals to stay healthy. Despite their potential
benefits for vision and cognition, lutein and zeaxanthin are
not currently considered as essential nutrients, and at present
there is no RDA guide for either lutein or zeaxanthin. Intakes of
approximately 6mg/day have been associated with a decreased
risk of age-related macular degeneration, however, the average
American adult consumes only 1-3 mg lutein/day and children
appear to consume even less120. For children, the importance of
their consumption relates more to the possibilities for optimisation of visual and cognitive development. This is evidenced by
the positive association between the quality of diet (particularly
increased intake of fruit and vegetables, rich sources of lutein
and zeaxanthin) and academic performance as demonstrated in
5th graders121. Although no RDA exists, the evidence cited herein
suggests that lutein and zeaxanthin intake levels during the
important developmental stages of childhood appears to be highly
variable and potentially deficient in many cases throughout all
stages of child development.
Of note, nano-encapsulation of carotenoids should be considered
as it may enhance the potential of carotenoids for brain function, by increasing stability and bioavailability. The cognitiveenhancing benefits of encapsulated lutein was shown in a study
in mice whose performance in a recognition memory task was
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significantly increased after administration of encapsulated lutein
compared to administration of free lutein122.
Obesity represents another potentially important consideration, with childhood obesity becoming increasingly common
across the globe which raises concerns relating to changing diet
patterns with processed, sugar-laden foods replacing fruit and
vegetables. In addition to its detrimental metabolic effects,
increased adiposity has been shown to be related to brain health
and cognitive function123. Although the consequences of childhood obesity for cognitive development are as yet unknown,
it is likely that the effects of excessive body fat and metabolic
misbalance on cognitive development are pronounced during
childhood, when the brain is still developing and experiences a
high degree of plasticity124. Interestingly, adipose tissue is the
major storage organ for carotenoids outside the CNS125, and there
appears to be an inverse relationship between MPOD and
measures of obesity126,127. It has been suggested that body fat
acts as a reservoir for lutein and zeaxanthin128, with excessive
adiposity and its associated metabolic changes (such as an unfavourable ratio of low- to high-density lipoproteins) potentially
contributing to impaired transport and delivery of lutein and
zeaxanthin to the eye and the brain129. The possible impact of
the obesity epidemic on retinal and brain carotenoid levels and
associated visual and cognitive function remain to be seen, and
have yet to be explored empirically.

Conclusions
Nutrition during the pre- and early postnatal period of life may
have a key role for the prevention of neurodegeneration later in
life130. It is possible that simple dietary modification or supplementation with a dietary antioxidant and anti-inflammatory
agent such as lutein might exert a tangible impact on early
neural development as well as on the delay of age-related
cognitive decline22,38,131. The beneficial role of lutein and zeaxanthin for the structural integrity and function of the ageing
brain has been demonstrated across numerous studies11. Much
less is known about their role during infancy, childhood and
pre-adolescence, the critical periods of brain development.

The findings of positive associations between MPOD and
cognitive abilities in children provide some initial evidence
for the role of lutein and zeaxanthin in cognitive development.
Indeed, there are numerous potential mechanisms by which
lutein and zeaxanthin may protect and enhance retinal and
brain function, and thereby support cognitive development in
children, including their antioxidant, anti-inflammatory and
neuroprotective properties (see Figure 2). Although not yet
supported by intervention trials, these findings highlight the
importance of habitual intake of lutein and zeaxanthin in
children.
However, the specific linkages between the intake of lutein
and zeaxanthin, their biological effects and clinical outcomes
in children need to be elucidated to provide the robust evidence
base that is needed to enlighten any beneficial effects of lutein
and zeaxanthin in early life. Although there is promising
preliminary evidence for a positive association between lutein
and cognitive performance in childhood, the cross-sectional
nature of the few studies available and the lack of RCTs, represents an evidence gap that merits further investigation before
any firm conclusions can be drawn. As there is currently
no RDA for lutein or zeaxanthin, studies demonstrating its
influence on cognition would contribute to the evidence base
supporting consideration of lutein and zeaxanthin as important
phytonutrients.
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